Projects per year
Personal profile
Chinese Name
禹志領
Biography
Prof. Yu received his undergraduate education at the Henan University of Traditional Chinese Medicine, and obtained his PhD degree in biochemistry from the Hong Kong University of Science and Technology. Before joining the Hong Kong Baptist University, Prof. Yu once worked at China Pharmaceutical University, Nagasaki University, Hong Kong University of Science and Technology, Xiamen University and University of Macau. Prof. Yu is known for his research in herbal pharmacology, and in processing of Chinese medicinal materials. He has published more than 200 peer-reviewed research papers.
Consun Pharmaceutical Group Limited and Laboratory JaneClare Limited in collaboration with Prof. Yu's team established "Consun Chinese Medicines Research Centre for Renal Diseases" and "JaneClare Transdermal TCM Therapy Laboratory", respectively, in Hong Kong Baptist University.
Prof. Yu serves as Editorial Board Member/Associate Editor/Executive Editor/ Consulting Editor for more than 30 journals, e.g. LiShizhen Medicine and Materia Medica Research, BMC Complementary Medicine and Therapies, Current Topics in Nutraceutical Research, Journal of Alternative, Complementary & Integrative Medicine, Pharmacological Research.
Research Interests
1) Pharmacology of Chinese medicines, focusing on the mechanisms of action of anticancer, anti-inflammation and melanogenesis-modulation herbs; 2) Unique processing of Chinese medicinal herbs, focusing on the mechanisms underlying processing of Chinese medicines, standardization of adjuvant materials for the processing of Chinese medicinal herbs, and quality control of decoction pieces.
Fingerprint
Dive into the research topics where Zhiling YU is active. Topic labels come from the works of this scholar.
- 1 Similar Scholars
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Screening, design, and optimization of pre-clinical agents from TCM-derived compounds
YU, Z. (PI)
10/09/26 → 31/12/99
Project: Research project
-
Research and Development of Transdermal Therapeutic Products Based on Traditional Chinese Medicine
YU, Z. (PI)
1/05/26 → 30/04/31
Project: Research project
-
燈盞生脉膠囊抗缺血性腦中風的靶點機制解析及智能分子複方開發
Tu, P. (PI), YU, Z. (CoI), Zeng, K. (CoI), Chen, P. (CoPI), LYU, A. (CoPI), Li, S. (CoPI) & Sun, X. (CoPI)
1/04/26 → 31/03/29
Project: Research project
-
Atractylenolide II sensitizes hepatocellular carcinoma to sorafenib and reduces sorafenib-induced hepatotoxicity: a preclinical pharmacological study
FU, X. (PI) & YU, Z. (CoI)
1/01/26 → 31/12/28
Project: Research project
-
Targeting Chk1 and CDK2: A Novel Therapeutic Strategy for Cutaneous Melanoma
YU, Z. (PI), FU, X. (CoI) & XIA, Y. (CoI)
1/11/25 → 31/10/27
Project: Research project
-
Anti-obesity mechanisms of adzuki bean saponin: a multi-omics and experimental study
Luo, J. (Co-first author), Luo, J. (Co-first author), Wu, Y. (Co-first author), Liu, B., Wang, N., Han, B., Yu, Z. & Xu, B., 5 Jun 2026, In: npj Science of Food. 10, 1, 21 p., 278.Research output: Contribution to journal › Journal article › peer-review
Open Access1 Citation (Scopus) -
Biochanin A alleviates HFD-Induced MAFLD by inhibiting IRE1α-SPT-ceramide axis and improving intestinal homeostasis
Liu, N. (Co-first author), Wang, R. (Co-first author), Gao, Y. (Co-first author), Wei, H., Xu, F., Chen, S., Yu, Z., Chen, L., Fan, X., Qiu, J. & Dou, X., Sept 2026, In: Phytomedicine. 159, 15 p., 158558.Research output: Contribution to journal › Journal article › peer-review
-
PIM1-induced Drp1 phosphorylation disrupts microglial mitophagy and aggravates neuroinflammation
Liu, X. (Co-first author), Ma, L. (Co-first author), Ma, X. (Co-first author), Ma, X. (Co-first author), Fang, X., Liu, Y., Su, Z., Liu, X., Yu, Z. & Chen, X., Aug 2026, In: Pharmacological Research. 230, 19 p., 108313.Research output: Contribution to journal › Journal article › peer-review
Open Access -
Si-Jun-Zi-Tang potentiates temozolomide's anti-melanoma efficacy and reduces its hepatotoxicity
Li, A. S. M., Wang, L., Fan, X.-Y., Wang, X.-Q., Wu, Y., Wu, J.-Y., Bai, J.-X., Han, R.-X., He, J.-J., Fu, X.-Q. & Yu, Z.-L., Apr 2026, In: Phytomedicine. 153, 17 p., 158012.Research output: Contribution to journal › Journal article › peer-review
Open Access1 Citation (Scopus) -
WCN26-5932 Pharmacological Effects and Mechanisms of Da-Yu-Gong Decoction in the Treatment of Mesangial Proliferative Glomerulonephritis
Chen, S., Fu, X.-Q., Yang, J., Du, Y. & Yu, Z.-L., Apr 2026, In: Kidney International Reports. 11, 4, Supplement, 2 p., 104488.Research output: Contribution to journal › Conference article › peer-review
Open Access
Prizes
-
2025年度廣東省科學技術獎-科技進步獎一等獎
Xiao, W. (Recipient), Wang, J. (Recipient), Wei, L. (Recipient), Chen, A. (Recipient), Du, Y. (Recipient), Zhao, X. (Recipient), YU, Z. (Recipient), Sun, X. (Recipient), Wang, M. (Recipient), Wang, R. (Recipient), Wang, M. (Recipient), Diao, J. (Recipient), Chen, J. (Recipient), Yuan, H. (Recipient) & Ma, Y. (Recipient), 19 Jun 2026
Prize: Award
File -
File
-
Certificate for Excellence for an abstract presented at the 2022 World Federation of Chinese Medicine Societies Meeting
FAN, X. (Recipient), WU, Y. (Recipient), FU, X. (Recipient) & YU, Z. (Recipient), 23 Jun 2023
Prize: Award
File -
Activities
-
BMC Complementary Medicine and Therapies (Journal)
YU, Z. (Member of editorial board)
1 Jan 2026 → …Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
Drug Resistance Updates (Journal)
YU, Z. (Member of editorial board)
1 Nov 2025 → …Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
药食同源中草药在认知障碍中的应用
YU, Z. (Speaker)
7 Jun 2024Activity: Conference/talk/lecture/symposium/speech/workshop, etc › Event organized by non-HKBU units
-
Concurrent inhibition of TLR4/MD2 and EGFR is a novel strategy for cancer treatment
YU, Z. (Plenary/keynote speaker)
26 Sept 2024Activity: Conference/talk/lecture/symposium/speech/workshop, etc › Event organized by non-HKBU units
-
A two-herb TCM formula: potential in treating rheumatoid arthritis
YU, Z. (Plenary/keynote speaker)
19 Sept 2024 → 20 Sept 2024Activity: Conference/talk/lecture/symposium/speech/workshop, etc › Event organized by non-HKBU units